POC troponin helps patients avoid unnecessary hospitalization

Point-of-care (POC) high-sensitivity troponin tests could significantly aid in patient risk assessments, allowing clinicians to assess all available data during the patient encounter, facilitating single-sample rule-out and potentially avoiding unnecessary hospitalization. Professor Paul Collinson, former Consultant Chemical Pathologist, Professor of Cardiovascular Biomarkers and Honorary Consultant Cardiologist at St Georges University Hospitals NHS Foundation Trust, discusses the impact and requirements for POC high-sensitivity troponin to be integrated within the clinical care process and how successful implementation can improve healthcare.